The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / August / Is Your Pathology AI Really Ready
Guidelines and Recommendations Digital and computational pathology Laboratory management Digital Pathology Software and hardware Technology and innovation

Is Your Pathology AI Really Ready?

New guidance explains why validating AI across scanners is essential for safe, reliable use in routine pathology

By Jessica Allerton 08/18/2026 Discussion 5 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Quiz

Share

Clinical Report: Is Your Pathology AI Really Ready?

Overview

The Digital Pathology Association has published new recommendations addressing the validation of AI tools in pathology, emphasizing the need for separate validation of scanners and AI algorithms.

Background

As AI technology advances in pathology, its implementation has outpaced the establishment of necessary validation standards. Many healthcare organizations are deploying AI tools without confirming their compatibility with the scanners used for digital pathology images.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

  • AI tools in pathology must be validated for the specific scanners used to generate digital images.
  • Validation is crucial as AI models can lose accuracy when analyzing images from different scanners.
  • The recommendations provide a roadmap for laboratories to implement AI safely and consistently.
  • Scanner validation and AI validation should be conducted separately to identify performance issues accurately.
  • Quality control measures are essential for detecting technical failures in AI applications.

Clinical Implications

Pathology laboratories should validate both digital slide scanners and AI algorithms to ensure diagnostic performance.

Conclusion

The DPA's guidance provides recommendations for laboratories integrating AI into pathology.

Related Resources & Content

  1. Digital Pathology Association, AI in Precision Oncology, 2025 -- Is Your Pathology AI Really Ready?
  2. FDA, Marketing Submission Recommendations for AI-Enabled Device Software Functions, 2025 -- Guidance Document
  3. CAP, Digital Pathology Codes -- Coding and Reimbursement Policy
  4. the pathologist — Can We Keep Diagnostic Autonomy in an AI World?
  5. the pathologist — Pathologists Versus AI
  6. the pathologist — Five Questions for an AI Pathologist
  7. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions | FDA
  8. Digital Pathology Codes - CAP
  9. Towards robust foundation models for digital pathology | Nature Communications

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Microbiology and climate change: Building a sustainable future together
Guidelines and Recommendations
Microbiology and climate change: Building a sustainable future together

January 27, 2022

1 min read

Serum Rhubarb Please… Stat!
Guidelines and Recommendations
Serum Rhubarb Please… Stat!

February 25, 2022

10 min read

We must weigh the benefits and risks of every test we perform – our patients’ lives hang in the balance

The Need for Nuance in a Polarizing Pandemic
Guidelines and Recommendations
The Need for Nuance in a Polarizing Pandemic

July 27, 2022

4 min read

From politics to pandemic fatigue, the long road from 2020 came with a series of hurdles that stopped an effective response in its tracks

IVDR Compliance: A Marathon, Not a Sprint
Guidelines and Recommendations
IVDR Compliance: A Marathon, Not a Sprint

September 13, 2022

3 min read

Reaching the IVDR compliance finishing line requires significant time and resources – but it’s an investment that will pay off in spades

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.